FBP2 and telomere syndrome: Huangyang et al. reported that the expression level of gluconeogenic isozyme fructose-1,6-bisphosphatase 2 (FBP2) was down-regulated in most subtypes of STS, and the re-expression of FBP2 significantly inhibited tumor growth (Huangyang et al., 2020).